PAX: Changes in Host Gene Expression to Differentiate Between Systemic Inflammation and Infection After Major Surgery
Study Details
Study Description
Brief Summary
Changes in host gene expression may provide additional information to diagnose postoperative infection and improve outcome after surgery. This study aims to validate the early diagnostic performance of specific gene signatures for differentiating infection from non-infected SIRS or uncomplicated postoperative course in blood sampes of adult patients undergoing major noncardiac surgery.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Rationale: Differentiation between the systemic inflammatory response syndrome (SIRS) and infection after surgery is challenging. Consequent diagnostic uncertainty may result in delayed diagnosis and interventions to prevent organ dysfunction or eventually death. Changes in host gene expression may provide additional information to diagnose postoperative infection and improve outcome after surgery.
Objective: To validate the early diagnostic performance of specific gene signatures1 for differentiating infection from non-infected SIRS or uncomplicated postoperative course.
Study design: A prospective observational multicenter study. Study population: Adult patients undergoing major noncardiac surgery. Main study parameters/endpoints: Main study parameters are specific gene signatures. Main study endpoint is postoperative infection and SIRS.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In each patient blood samples will be drawn for analysis on the following time points: after induction for anaesthesia, directly postoperative and on postoperative day 1 - 7. For each sample 2.5 ml of blood is taken. In a total of 9 samples this results in a cumulative volume of 22.5 ml. Whenever possible, blood samples will be drawn simultaneously with routine perioperative laboratory testing. In case of admission to the Intensive Care Unit blood samples will be collected using an arterial line. There are no direct risks or benefits for patients included in the study.
Study Design
Outcome Measures
Primary Outcome Measures
- Postoperative infection [30 days]
Secondary Outcome Measures
- Postoperative SIRS [30 days]
- Postoperative sepsis [30 days]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Age >18 years, major noncardiac surgery with infection risk >20% (e.g., pancreatic surgery, esophageal resection surgery, colorectal surgery, hyperthermic intraperitoneal chemotherapy (HIPEC) surgery).
Exclusion Criteria:
- Age <18 years, emergency surgery, inability to provide informed consent.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- St. Antonius Hospital
- Amphia Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NL